Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, affecting approximately 335 million patients worldwide. Comprehensive pharmacological treatment of AF includes medications for rate or rhythm control and anticoagulants to reduce the risk of thromboembolism; yet, these agents have si...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Nazrul, Cichero, Emma, Rahman, Shafiqur, Ranasinghe, Isuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845156/
https://www.ncbi.nlm.nih.gov/pubmed/36255655
http://dx.doi.org/10.1007/s40256-022-00551-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845156/
https://www.ncbi.nlm.nih.gov/pubmed/36255655
http://dx.doi.org/10.1007/s40256-022-00551-8

Ejemplares similares